ID   RHG07_MOUSE             Reviewed;        1092 AA.
AC   Q9R0Z9; Q3TRX3; Q3UH75; Q8R541;
DT   08-NOV-2002, integrated into UniProtKB/Swiss-Prot.
DT   08-NOV-2002, sequence version 2.
DT   07-APR-2021, entry version 154.
DE   RecName: Full=Rho GTPase-activating protein 7;
DE   AltName: Full=Deleted in liver cancer 1 protein homolog;
DE            Short=DLC-1;
DE   AltName: Full=Rho-type GTPase-activating protein 7;
DE   AltName: Full=START domain-containing protein 12;
DE            Short=StARD12;
DE   AltName: Full=StAR-related lipid transfer protein 12;
GN   Name=Dlc1; Synonyms=Arhgap7, Stard12;
OS   Mus musculus (Mouse).
OC   Eukaryota; Metazoa; Chordata; Craniata; Vertebrata; Euteleostomi; Mammalia;
OC   Eutheria; Euarchontoglires; Glires; Rodentia; Myomorpha; Muroidea; Muridae;
OC   Murinae; Mus; Mus.
OX   NCBI_TaxID=10090;
RN   [1]
RP   NUCLEOTIDE SEQUENCE [MRNA] (ISOFORM 1).
RC   STRAIN=129/Sv;
RX   PubMed=10702663; DOI=10.1159/000015462;
RA   Yuan B.-Z., Keck-Waggoner C.L., Zimonjic D.B., Thorgeirsson S.S.,
RA   Popescu N.C.;
RT   "Assignment and cloning of mouse Arhgap7 to chromosome 8A4-B2, a conserved
RT   syntenic region of human chromosome 8p22-p21.";
RL   Cytogenet. Cell Genet. 87:189-190(1999).
RN   [2]
RP   NUCLEOTIDE SEQUENCE [GENOMIC DNA] (ISOFORM 1).
RC   STRAIN=129/Sv;
RX   PubMed=12034501; DOI=10.1016/s0378-1119(02)00462-6;
RA   Durkin M.E., Yuan B.-Z., Thorgeirsson S.S., Popescu N.C.;
RT   "Gene structure, tissue expression, and linkage mapping of the mouse DLC-1
RT   gene (Arhgap7).";
RL   Gene 288:119-127(2002).
RN   [3]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA] (ISOFORM 2), AND NUCLEOTIDE SEQUENCE
RP   [LARGE SCALE MRNA] OF 1-1064 (ISOFORM 1).
RC   STRAIN=C57BL/6J; TISSUE=Brain, and Diencephalon;
RX   PubMed=16141072; DOI=10.1126/science.1112014;
RA   Carninci P., Kasukawa T., Katayama S., Gough J., Frith M.C., Maeda N.,
RA   Oyama R., Ravasi T., Lenhard B., Wells C., Kodzius R., Shimokawa K.,
RA   Bajic V.B., Brenner S.E., Batalov S., Forrest A.R., Zavolan M., Davis M.J.,
RA   Wilming L.G., Aidinis V., Allen J.E., Ambesi-Impiombato A., Apweiler R.,
RA   Aturaliya R.N., Bailey T.L., Bansal M., Baxter L., Beisel K.W., Bersano T.,
RA   Bono H., Chalk A.M., Chiu K.P., Choudhary V., Christoffels A.,
RA   Clutterbuck D.R., Crowe M.L., Dalla E., Dalrymple B.P., de Bono B.,
RA   Della Gatta G., di Bernardo D., Down T., Engstrom P., Fagiolini M.,
RA   Faulkner G., Fletcher C.F., Fukushima T., Furuno M., Futaki S.,
RA   Gariboldi M., Georgii-Hemming P., Gingeras T.R., Gojobori T., Green R.E.,
RA   Gustincich S., Harbers M., Hayashi Y., Hensch T.K., Hirokawa N., Hill D.,
RA   Huminiecki L., Iacono M., Ikeo K., Iwama A., Ishikawa T., Jakt M.,
RA   Kanapin A., Katoh M., Kawasawa Y., Kelso J., Kitamura H., Kitano H.,
RA   Kollias G., Krishnan S.P., Kruger A., Kummerfeld S.K., Kurochkin I.V.,
RA   Lareau L.F., Lazarevic D., Lipovich L., Liu J., Liuni S., McWilliam S.,
RA   Madan Babu M., Madera M., Marchionni L., Matsuda H., Matsuzawa S., Miki H.,
RA   Mignone F., Miyake S., Morris K., Mottagui-Tabar S., Mulder N., Nakano N.,
RA   Nakauchi H., Ng P., Nilsson R., Nishiguchi S., Nishikawa S., Nori F.,
RA   Ohara O., Okazaki Y., Orlando V., Pang K.C., Pavan W.J., Pavesi G.,
RA   Pesole G., Petrovsky N., Piazza S., Reed J., Reid J.F., Ring B.Z.,
RA   Ringwald M., Rost B., Ruan Y., Salzberg S.L., Sandelin A., Schneider C.,
RA   Schoenbach C., Sekiguchi K., Semple C.A., Seno S., Sessa L., Sheng Y.,
RA   Shibata Y., Shimada H., Shimada K., Silva D., Sinclair B., Sperling S.,
RA   Stupka E., Sugiura K., Sultana R., Takenaka Y., Taki K., Tammoja K.,
RA   Tan S.L., Tang S., Taylor M.S., Tegner J., Teichmann S.A., Ueda H.R.,
RA   van Nimwegen E., Verardo R., Wei C.L., Yagi K., Yamanishi H.,
RA   Zabarovsky E., Zhu S., Zimmer A., Hide W., Bult C., Grimmond S.M.,
RA   Teasdale R.D., Liu E.T., Brusic V., Quackenbush J., Wahlestedt C.,
RA   Mattick J.S., Hume D.A., Kai C., Sasaki D., Tomaru Y., Fukuda S.,
RA   Kanamori-Katayama M., Suzuki M., Aoki J., Arakawa T., Iida J., Imamura K.,
RA   Itoh M., Kato T., Kawaji H., Kawagashira N., Kawashima T., Kojima M.,
RA   Kondo S., Konno H., Nakano K., Ninomiya N., Nishio T., Okada M., Plessy C.,
RA   Shibata K., Shiraki T., Suzuki S., Tagami M., Waki K., Watahiki A.,
RA   Okamura-Oho Y., Suzuki H., Kawai J., Hayashizaki Y.;
RT   "The transcriptional landscape of the mammalian genome.";
RL   Science 309:1559-1563(2005).
RN   [4]
RP   PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-86 AND SER-89, AND
RP   IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RC   TISSUE=Liver;
RX   PubMed=17242355; DOI=10.1073/pnas.0609836104;
RA   Villen J., Beausoleil S.A., Gerber S.A., Gygi S.P.;
RT   "Large-scale phosphorylation analysis of mouse liver.";
RL   Proc. Natl. Acad. Sci. U.S.A. 104:1488-1493(2007).
RN   [5]
RP   PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-86 AND SER-89, AND
RP   IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RC   TISSUE=Brain, Brown adipose tissue, Heart, Kidney, Liver, Lung, and Testis;
RX   PubMed=21183079; DOI=10.1016/j.cell.2010.12.001;
RA   Huttlin E.L., Jedrychowski M.P., Elias J.E., Goswami T., Rad R.,
RA   Beausoleil S.A., Villen J., Haas W., Sowa M.E., Gygi S.P.;
RT   "A tissue-specific atlas of mouse protein phosphorylation and expression.";
RL   Cell 143:1174-1189(2010).
CC   -!- FUNCTION: Functions as a GTPase-activating protein for the small
CC       GTPases RHOA, RHOB, RHOC and CDC42, terminating their downstream
CC       signaling. This induces morphological changes and detachment through
CC       cytoskeletal reorganization, playing a critical role in biological
CC       processes such as cell migration and proliferation. Also functions in
CC       vivo as an activator of the phospholipase PLCD1. Active DLC1 increases
CC       cell migration velocity but reduces directionality (By similarity).
CC       {ECO:0000250}.
CC   -!- SUBUNIT: Interacts with EF1A1, facilitates EF1A1 distribution to the
CC       membrane periphery and ruffles upon growth factor stimulation and
CC       suppresses cell migration. {ECO:0000250}.
CC   -!- SUBCELLULAR LOCATION: Cytoplasm {ECO:0000250}. Cell junction, focal
CC       adhesion {ECO:0000250}. Membrane {ECO:0000250}; Peripheral membrane
CC       protein {ECO:0000250}. Note=Colocalizes with EF1A1 at actin-rich
CC       regions in the cell periphery. {ECO:0000250}.
CC   -!- ALTERNATIVE PRODUCTS:
CC       Event=Alternative splicing; Named isoforms=2;
CC       Name=1;
CC         IsoId=Q9R0Z9-1; Sequence=Displayed;
CC       Name=2;
CC         IsoId=Q9R0Z9-2; Sequence=VSP_026144;
CC   -!- TISSUE SPECIFICITY: Widely expressed with the highest levels in heart,
CC       liver and lung.
CC   -!- DOMAIN: The SAM domain mediates interaction with EF1A1, and functions
CC       as an autoinhibitory regulator of RhoGAP Activity. {ECO:0000250}.
CC   -!- DOMAIN: The polybasic cluster is required for activation and mediates
CC       binding to phosphatidylinositol-4,5-bisphosphate (PI(4,5)P(2))
CC       containing membranes. {ECO:0000250}.
CC   -!- SEQUENCE CAUTION:
CC       Sequence=AAL87620.1; Type=Erroneous initiation; Evidence={ECO:0000305};
CC   ---------------------------------------------------------------------------
CC   Copyrighted by the UniProt Consortium, see https://www.uniprot.org/terms
CC   Distributed under the Creative Commons Attribution (CC BY 4.0) License
CC   ---------------------------------------------------------------------------
DR   EMBL; AF178078; AAD51760.1; -; mRNA.
DR   EMBL; AF411442; AAL87620.1; ALT_INIT; Genomic_DNA.
DR   EMBL; AF411435; AAL87620.1; JOINED; Genomic_DNA.
DR   EMBL; AF411436; AAL87620.1; JOINED; Genomic_DNA.
DR   EMBL; AF411437; AAL87620.1; JOINED; Genomic_DNA.
DR   EMBL; AF411438; AAL87620.1; JOINED; Genomic_DNA.
DR   EMBL; AF411439; AAL87620.1; JOINED; Genomic_DNA.
DR   EMBL; AF411440; AAL87620.1; JOINED; Genomic_DNA.
DR   EMBL; AF411441; AAL87620.1; JOINED; Genomic_DNA.
DR   EMBL; AK147539; BAE27982.1; -; mRNA.
DR   EMBL; AK162413; BAE36903.1; -; mRNA.
DR   CCDS; CCDS40322.1; -. [Q9R0Z9-1]
DR   CCDS; CCDS57616.1; -. [Q9R0Z9-2]
DR   RefSeq; NP_001181870.1; NM_001194941.1.
DR   RefSeq; NP_056617.2; NM_015802.3.
DR   SMR; Q9R0Z9; -.
DR   BioGRID; 206100; 1.
DR   IntAct; Q9R0Z9; 1.
DR   STRING; 10090.ENSMUSP00000033923; -.
DR   iPTMnet; Q9R0Z9; -.
DR   PhosphoSitePlus; Q9R0Z9; -.
DR   jPOST; Q9R0Z9; -.
DR   PaxDb; Q9R0Z9; -.
DR   PRIDE; Q9R0Z9; -.
DR   ProteomicsDB; 253275; -. [Q9R0Z9-1]
DR   ProteomicsDB; 253276; -. [Q9R0Z9-2]
DR   GeneID; 50768; -.
DR   KEGG; mmu:50768; -.
DR   CTD; 10395; -.
DR   MGI; MGI:1354949; Dlc1.
DR   eggNOG; KOG2200; Eukaryota.
DR   InParanoid; Q9R0Z9; -.
DR   PhylomeDB; Q9R0Z9; -.
DR   Reactome; R-MMU-194840; Rho GTPase cycle.
DR   BioGRID-ORCS; 50768; 0 hits in 53 CRISPR screens.
DR   ChiTaRS; Dlc1; mouse.
DR   PRO; PR:Q9R0Z9; -.
DR   Proteomes; UP000000589; Unplaced.
DR   RNAct; Q9R0Z9; protein.
DR   GO; GO:0005901; C:caveola; ISO:MGI.
DR   GO; GO:0030864; C:cortical actin cytoskeleton; ISO:MGI.
DR   GO; GO:0005737; C:cytoplasm; ISO:MGI.
DR   GO; GO:0005829; C:cytosol; ISO:MGI.
DR   GO; GO:0005925; C:focal adhesion; ISO:MGI.
DR   GO; GO:0045121; C:membrane raft; ISO:MGI.
DR   GO; GO:0005634; C:nucleus; ISO:MGI.
DR   GO; GO:0032587; C:ruffle membrane; ISO:MGI.
DR   GO; GO:0005096; F:GTPase activator activity; ISO:MGI.
DR   GO; GO:0008289; F:lipid binding; IEA:InterPro.
DR   GO; GO:0043274; F:phospholipase binding; ISO:MGI.
DR   GO; GO:0042169; F:SH2 domain binding; ISO:MGI.
DR   GO; GO:0017166; F:vinculin binding; ISO:MGI.
DR   GO; GO:0030036; P:actin cytoskeleton organization; IMP:MGI.
DR   GO; GO:0006919; P:activation of cysteine-type endopeptidase activity involved in apoptotic process; ISO:MGI.
DR   GO; GO:0007202; P:activation of phospholipase C activity; ISO:MGI.
DR   GO; GO:0006915; P:apoptotic process; ISO:MGI.
DR   GO; GO:0007010; P:cytoskeleton organization; ISO:MGI.
DR   GO; GO:0048041; P:focal adhesion assembly; IMP:MGI.
DR   GO; GO:0030900; P:forebrain development; IMP:MGI.
DR   GO; GO:0003007; P:heart morphogenesis; IMP:MGI.
DR   GO; GO:0021575; P:hindbrain morphogenesis; IMP:MGI.
DR   GO; GO:0030336; P:negative regulation of cell migration; ISO:MGI.
DR   GO; GO:0008285; P:negative regulation of cell population proliferation; ISS:UniProtKB.
DR   GO; GO:0051895; P:negative regulation of focal adhesion assembly; ISO:MGI.
DR   GO; GO:0035024; P:negative regulation of Rho protein signal transduction; ISO:MGI.
DR   GO; GO:0051497; P:negative regulation of stress fiber assembly; ISO:MGI.
DR   GO; GO:0001843; P:neural tube closure; IMP:MGI.
DR   GO; GO:1900119; P:positive regulation of execution phase of apoptosis; ISO:MGI.
DR   GO; GO:0035307; P:positive regulation of protein dephosphorylation; ISO:MGI.
DR   GO; GO:0032956; P:regulation of actin cytoskeleton organization; ISO:MGI.
DR   GO; GO:0008360; P:regulation of cell shape; ISO:MGI.
DR   GO; GO:0035023; P:regulation of Rho protein signal transduction; IBA:GO_Central.
DR   GO; GO:0007165; P:signal transduction; IEA:InterPro.
DR   Gene3D; 1.10.555.10; -; 1.
DR   Gene3D; 3.30.530.20; -; 1.
DR   InterPro; IPR028854; DLC1.
DR   InterPro; IPR008936; Rho_GTPase_activation_prot.
DR   InterPro; IPR000198; RhoGAP_dom.
DR   InterPro; IPR001660; SAM.
DR   InterPro; IPR013761; SAM/pointed_sf.
DR   InterPro; IPR023393; START-like_dom_sf.
DR   InterPro; IPR002913; START_lipid-bd_dom.
DR   PANTHER; PTHR12659:SF2; PTHR12659:SF2; 1.
DR   Pfam; PF00620; RhoGAP; 1.
DR   Pfam; PF07647; SAM_2; 1.
DR   Pfam; PF01852; START; 1.
DR   SMART; SM00324; RhoGAP; 1.
DR   SMART; SM00234; START; 1.
DR   SUPFAM; SSF47769; SSF47769; 1.
DR   SUPFAM; SSF48350; SSF48350; 1.
DR   PROSITE; PS50238; RHOGAP; 1.
DR   PROSITE; PS50848; START; 1.
PE   1: Evidence at protein level;
KW   Alternative splicing; Cell junction; Cytoplasm; GTPase activation;
KW   Membrane; Phosphoprotein; Reference proteome; Tumor suppressor.
FT   CHAIN           1..1092
FT                   /note="Rho GTPase-activating protein 7"
FT                   /id="PRO_0000056708"
FT   DOMAIN          11..78
FT                   /note="SAM"
FT   DOMAIN          642..848
FT                   /note="Rho-GAP"
FT                   /evidence="ECO:0000255|PROSITE-ProRule:PRU00172"
FT   DOMAIN          878..1085
FT                   /note="START"
FT                   /evidence="ECO:0000255|PROSITE-ProRule:PRU00197"
FT   REGION          275..448
FT                   /note="Focal adhesion-targeting (FAT)"
FT                   /evidence="ECO:0000250"
FT   REGION          615..637
FT                   /note="Polybasic cluster (PBR)"
FT                   /evidence="ECO:0000250"
FT   COMPBIAS        306..312
FT                   /note="Poly-Ser"
FT   COMPBIAS        432..438
FT                   /note="Poly-Ser"
FT   MOD_RES         86
FT                   /note="Phosphoserine"
FT                   /evidence="ECO:0007744|PubMed:17242355,
FT                   ECO:0007744|PubMed:21183079"
FT   MOD_RES         89
FT                   /note="Phosphoserine"
FT                   /evidence="ECO:0007744|PubMed:17242355,
FT                   ECO:0007744|PubMed:21183079"
FT   MOD_RES         129
FT                   /note="Phosphoserine"
FT                   /evidence="ECO:0000250|UniProtKB:Q63744"
FT   MOD_RES         322
FT                   /note="Phosphoserine"
FT                   /evidence="ECO:0000250|UniProtKB:Q96QB1"
FT   VAR_SEQ         1..13
FT                   /note="MCRDEPDTMILTQ -> MGDPEGHVMARPLRGPLRRSFSDHIRDSTARALDA
FT                   IWKNTRERRLAE (in isoform 2)"
FT                   /evidence="ECO:0000303|PubMed:16141072"
FT                   /id="VSP_026144"
FT   CONFLICT        42
FT                   /note="V -> I (in Ref. 3; BAE36903/BAE27982)"
FT                   /evidence="ECO:0000305"
FT   CONFLICT        120
FT                   /note="F -> S (in Ref. 3; BAE36903/BAE27982)"
FT                   /evidence="ECO:0000305"
FT   CONFLICT        192
FT                   /note="G -> R (in Ref. 1; AAD51760)"
FT                   /evidence="ECO:0000305"
FT   CONFLICT        421..422
FT                   /note="HD -> SH (in Ref. 1; AAD51760)"
FT                   /evidence="ECO:0000305"
FT   CONFLICT        715..717
FT                   /note="KQY -> NRN (in Ref. 1; AAD51760)"
FT                   /evidence="ECO:0000305"
FT   CONFLICT        730..735
FT                   /note="LSETFL -> FSEPSM (in Ref. 1; AAD51760)"
FT                   /evidence="ECO:0000305"
FT   CONFLICT        917
FT                   /note="D -> E (in Ref. 3; BAE36903/BAE27982)"
FT                   /evidence="ECO:0000305"
SQ   SEQUENCE   1092 AA;  123367 MW;  9B5DC3103986A751 CRC64;
     MCRDEPDTMI LTQIEAKEAC DWLRVTGFPQ YAQLYEDLLF PVDIALVKRE HDFLDRDAIE
     ALCRRLNTLN KCAVMKLEIS PHRKRSEDSD EDEPCAISGK WTFQRDSKRW SRLEEFDVFF
     PKQDPIPGSP DNSRLQSATS HESMLTDLSE HQEVASVRSL SSTSSSVPTH AAHSGDATTP
     RTNSVISVCS SGHFVGNDDS FSSLPSPKEL SSFSFSMKGH HEKNTKSKTR SLLKRMESLK
     LKGSHHSKHK APSKLGLIIS APILQEGMDE AKLKQLNCVE ISALNGNHIN VPMVRKRSVS
     NSTQTSSSSS QSETSSAVST PSPVTRTRSL STCNKRVGMY LEGFDPFSQS TLNNVTEQNY
     KNRESYPEDT VFYIPEDHKP GTFPKALSHG SFCPSGNSSV NWRTGSFHGP GHLSLRRENS
     HDSPKELKRR NSSSSLSSRL SIYDNVPGSI LYSSSGELAD LENEDIFPEL DDILYHVKGM
     QRIVNQWSEK FSDEGDSDSA LDSVSPCPSS PKQIHLDVDH DRRTPSDLDS TGNSLNEPEE
     PTDIPERRDS GVGASLTRCN RHRLRWHSFQ SSHRPSLNSV SLQINCQSVA QMNLLQKYSL
     LKLTALLEKY TPSNKHGFSW AVPKFMKRIK VPDYKDRSVF GVPLTVNVQR SGQPLPQSIQ
     QAMRYLRNHC LDQVGLFRKS GVKSRIQALR QMNESAEDNV NYEGQSAYDV ADMLKQYFRD
     LPEPLMTNKL SETFLQIYQY VPKDQRLQAI KAAIMLLPDE NREVLQTLLY FLSDVTAAVK
     ENQMTPTNLA VCLAPSLFHL NTLKRENSSP RVMQRKQSLG KPDQKDLNEN LAATQGLAHM
     IAECKKLFQV PEEMSRCRNS YTEQELKPLT LEALGHLNSD QPADYRHFLQ DCVDGLFKEV
     KEKFKGWVSY PTSEQADLSY KKVSEGPPLR LWRSTIEVPA APEEILKRLL KEQHLWDVDL
     LDSKVIEILD SQTEIYQYVQ NSMAPHPARD YVVLRTWRTN LPRGACALLL TSVDHDRAPV
     AGVRVNVLLS RYLIEPCGSG KSKLTYMCRA DLRGHMPEWY SKSFGHLCAA EVVKIRDSFS
     NQNTESKDTR SR
//
